Adiposs SA
Imaging body fat to save lives.
Adiposs SA is a clinical-stage, top 100 Swiss life science start-up developing transformative imaging products and technologies.
20 million people get diagnosed with cancer and a staggering 10 million cancer patients die every year. This because 2 out of 3 cancer patients do not respond to therapy. Nobody knows who will respond.
Adiposs is developing the first and only contrast agent for brown fat in cancer patients called ImageBAT®. It is an add-on product to the standard-of-care CT / PET-CT cancer scan available in virtually all hospitals worldwide. ImageBAT® predicts the response to cancer therapy and enables personalised therapy with improved quality of life and survival on a global scale.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
01.07.2025
Adiposs secures CHF 4 Million to advance clinical trials (startupticker.ch)
01.07.2025
Adiposs Raises CHF 4M to advance cancer imaging tool (venturelab.swiss)
06.09.2024
Kickfund invests at full throttle (startupticker.ch)
13.08.2024
Four startups from the medical field obtain the Innosuisse Certificate (startupticker.ch)
10.10.2023
Promising breakthroughs in healthcare (startupticker.ch)
30.06.2025
23.06.2025
First subject dosed in IBT-002 imaging efficacy clinical trial
01.09.2023
Phase 1 clinical trial completed
14.07.2023
Equity round
25.05.2023
Winner of Swiss Startup Days 2023 Healthcare Pitching Competition
No Jobs
Videos
Early detection of cancer cachexia
Documents
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Venture Leaders Life Sciences
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
Adiposs SA
Imaging body fat to save lives.
Website:
adiposs.com
Headquarter:
Plan-les-Ouates
Foundation Date:
January 2020
Technology:
- Medtech
Sectors:
- Biotech
- Cancer
- Cardiovascular
- Diagnostics
- Imaging and Radiology
- Medtech
Support received
